BN Business News
Add your company to Business Communicator →

Regulation & law · 19/11/2020

Catalent Pharma Solutions Receives Authorization to Expand Production in New Jersey FTZ

Catalent Pharma Solutions, a leading pharmaceutical products manufacturer, has been authorized to expand its production activities in the Foreign-Trade Zone (FTZ) 49-Newark and Elizabeth, New Jersey, further solidifying its presence in the region.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights